Huisheng Biotechnology: Net profit of 253 million yuan in 2025.

In the financial report announced by Huisheng Biotechnology, the operating income in 2025 was 1.681 billion yuan, a year-on-year increase of 40.07%. The net profit was 253 million yuan. The profit distribution plan approved by the board of directors for this time is as follows: based on the total share capital of 202 million shares disclosed in this report, a cash dividend of 2 yuan will be distributed to all shareholders for every 10 shares held.